Figure 1.
Comparison of the local control rates between the miriplatin (solid line) and epirubicin (dotted line) groups in the targeted chemoembolization of hepatocellular carcinoma.
Note: The miriplatin group showed significantly higher local tumor progression as compared to the epirubicin group (P < 0.001).